Pacira BioSciences Overview
Pacira BioSciences Target Price
Analysts' 12-month price predictions for PCRX.
Share Price
$26.74
Average Target Price
$36.00
34.6% upside
34.6% upside2 analysts in the last 4 months
High: $48 | Low: $24
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-02-28 | Barclays | $24 |  10.2% downside |  |
| 2025-02-28 | H.C. Wainwright | $48 | 79.5% upside | |
| 2025-01-30 | Truist FinancialLes Sulewski | $25 | 6.5% downside | |
| 2024-11-07 | Piper SandlerDavid Amsellem | $12 | 55.1% downside | |
| 2024-09-24 | JefferiesGlen Santangelo | $18 | 32.7% downside | |
| 2024-08-13 | Truist FinancialLes Sulewski | $8 | 70.1% downside | |
| 2024-07-02 | H.C. WainwrightOren Livnat | $57 | 113.2% upside | |
| 2024-06-13 | JefferiesGlen Santangelo | $36 | 34.6% upside | |
| 2024-05-21 | Piper SandlerDavid Amsellem | $42 | 57.1% upside | |
| 2023-01-06 | BMO Capital | $52 | 94.5% upside | |
| 2023-01-06 | Needham | $63 | 135.6% upside | |